1-7 of 7
Mark Lanasa, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Response Rate of Moxetumomab Pasudotox in Relapsed/Refractory Hairy Cell Leukemia Includes Eradication of Minimal Residual Disease: Potential Importance for Outcome

Robert J. Kreitman, MD, Evgeny Arons, PhD, Martin S Tallman, MD, Robak Tadeusz, MD PhD, Steven Coutre, MD, Wyndham H Wilson, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Constance M. Yuan, MD PhD, Mark Lanasa, MD PhD, David JP FitzGerald, PhD, Ira Pastan, MD
Journal: Blood
Blood (2015) 126 (23): 4161.
https://doi.org/10.1182/blood.V126.23.4161.4161
Published: 2015
Journal Articles

Real-World Treatment Patterns and Outcomes Among Patients with Hairy Cell Leukemia

Sudeep Karve, PhD, Victoria Divino, BA, Andrew Gaughan, MSc, Mitch DeKoven, MHSA, Guozhi Gao, Mark Lanasa, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2125.
https://doi.org/10.1182/blood.V126.23.2125.2125
Published: 2015
Journal Articles

Exome-Wide Sequencing Reveals Oncogenic Mutations in Both Progressive and Non-Progressive MBL

Doreen te Raa, Mark Lanasa, MD PhD, Sallie Allgood, Paula Scotland, Cassie Love, Arend Jan van Houte, Douwe Biesma, Arnon P. Kater, MD PhD, Sandeep Dave, MD
Journal: Blood
Blood (2015) 126 (23): 361.
https://doi.org/10.1182/blood.V126.23.361.361
Published: 2015
Journal Articles

Healthcare Utilization and Costs Among Patients with Hairy Cell Leukemia: Analysis of a Large US Administrative Claims Database

Victoria Divino, BA, Sudeep Karve, PhD, Andrew Gaughan, MSc, Mitch DeKoven, MHSA, Guozhi Gao, Mark Lanasa, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4520.
https://doi.org/10.1182/blood.V126.23.4520.4520
Published: 2015
Journal Articles

Double IGHV Gene Rearrangements in Chronic Lymphocytic Leukemia

Benjamin M Heyman, MD, Alicia D. Volkheimer, MS, J. Brice Weinberg, MD, Mark Lanasa, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5631.
https://doi.org/10.1182/blood.V124.21.5631.5631
Published: 2014
Journal Articles

A Phase I Dose Escalation Study Of TGR-1202, a Novel PI3K-δ Inhibitor, For Patients With Relapsed Or Refractory Hematologic Malignancies

Michael Savona, MD, Martin Gutierrez, MD, Mark Lanasa, MD, PhD, Changchun Deng, MD, PhD, John Kuhn, PharmD, Lauren Sade, Hari Miskin, MS, Peter Sportelli, Swaroop Vakkalanka, PhD, Manish Patel, MD
Journal: Blood
Blood (2013) 122 (21): 4373.
https://doi.org/10.1182/blood.V122.21.4373.4373
Published: 2013
Journal Articles

Laboratory Correlates and a Phase I Clinical Trial Of Lenalidomide In Combination With Plerixafor In Patients With Previously Treated Chronic Lymphocytic Leukemia

Danielle M. Brander, MD, Sallie D. Allgood, MS, Tiffany M. Simms, BS, J. Brice Weinberg, MD, Mark Lanasa, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5301.
https://doi.org/10.1182/blood.V122.21.5301.5301
Published: 2013